Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Uqora is a health technology company focused on providing science-backed solutions for urinary tract health and the prevention of urinary tract infections (UTIs). Founded in 2017, the company develops non-antibiotic products designed to flush the urinary tract, disrupt biofilms, and support the vaginal microbiome. Their main product line includes Target, Control, and Promote, which utilize ingredients like D-mannose and specific probiotic strains to maintain bladder health. In 2021, Uqora was acquired by Pharmavite, the manufacturer of Nature Made supplements, to expand its portfolio in women's health. The company remains a leader in the proactive urinary health space, emphasizing clinical research and consumer education.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Uqora.